Randomized control trial: Comparison of triple therapy plus probiotic yogurt vs. standard triple therapy on helicobacter pylori eradication

Iranian Red Crescent Medical Journal

Volumn 14, Issue 10, 2012, Pages

  Mirzaee, V ^a   Rezahoseini, O ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Eradication; Helicobacter pylori; Probiotic yogurt; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PANTOPRAZOLE; PROBIOTIC AGENT; PROBIOTIC YOGURT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; DIARRHEA; DRUG EFFICACY; DYSGEUSIA; EDUCATIONAL STATUS; ERADICATION THERAPY; FEMALE; GROUPS BY AGE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 84870229910     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. The New England journal of medicine. 2001;345(11):784-9. PubMed PMID: 11556297.
2. Wotherspoon AC. A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Current gastroenterology reports. 2000;2(6):494-8. PubMed PMID: 11079052.
3. Siavoshi F, Malekzadeh R, Daneshmand M, Smoot DT, Ashktorab H. Association between Helicobacter pylori Infection in gastric cancer, ulcers and gastritis in Iranian patients. Helicobacter. 2004;9(5):470. PubMed PMID: 15361089.
4. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterology clinics ofi North America. 2000;29(3):559-578. PubMed PMID: 11030073.
5. McColl KE. Clinical practice. Helicobacter pylori infection. The New England journalofmedicine. 2010;362(17):1597-1604. PubMed PMID: 20427808.
6. Chey WD, Wong BC. AmericanCollege of Gastroenterology guideline on the management of Helicobacter pylori infection. The American journal of gastroenterology. 2007;102(8):1808-1825.PubMed PMID: 17608775.
7. Heydarian F, Kianifar HR, Ahanchian H, Khakshure A, Seyedi J, Moshirian D. A comparison between traditional yogurt and probiotic yogurt in non-inflammatoryacute gastroenteritis. Saudi medical journal. 2010;31(3):280-3.PubMed PMID: 20231933.
8. Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clinical and experimental immunology. 2007;149(3):470-9.PubMed PMID: 17590176.
9. Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PF. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS immunology and medical microbiology. 1999;26(2):131-5.PubMed PMID: 10536299.
10. Fedorak RN, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2008. Journal of clinical gastroenterology. 2008;42 Suppl 2:S97-103.PubMed PMID: 18542034.
11. Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics. 2002;16(9):1669-1675.PubMed PMID: 12197847.
12. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Alimentary pharmacology & therapeutics. 2002;16 Suppl 1:3-15.PubMed PMID: 11849122.
13. de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scandinavian journal of gastroenterology. 1995;30(5):401-7.PubMed PMID: 7638563.
14. Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song 15. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter. 2008;13(4):261-8.PubMed PMID: 18665934.
15. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Alimentary pharmacology & therapeutics. 2007;25(2):155-168.PubMed PMID: 17229240.
16. Latifi-Navid S, Ghorashi SA, Siavoshi F, Linz B, Massarrat S, Khegay T, Salmanian AH, Shayesteh AA, Masoodi M, Ghanadi K, Ganji A, Suerbaum S, Achtman M, Malekzadeh R, Falush D. Ethnic and geographic differentiation of Helicobacter pylori within Iran. PloS one. 2010;5(3):e9645.PubMed PMID: 20339588.